Response to: 'Autoantibodies and interstitial lung disease in rheumatoid arthritis: towards a 'mix-and-match' approach' by Alunno et al

Ann Rheum Dis. 2022 Apr;81(4):e54. doi: 10.1136/annrheumdis-2020-217432. Epub 2020 May 28.

Authors

Raul Castellanos-Moreira¹, Sebastian Cruz Rodríguez-García¹, Isabel Haro², Raimon Sanmarti³

Affiliations

¹ Rheumatology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
² Unit of Synthesis and Biomedical Applications of Peptides, Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Consejo Superior de Investigaciones Cientificas, Barcelona, Spain.
³ Rheumatology Department, Hospital Clinic de Barcelona, Barcelona, Spain [email protected].

PMID: 32467249
DOI: 10.1136/annrheumdis-2020-217432

No abstract available

Keywords: anti-citrullinated protein antibodies; arthritis, rheumatoid; autoantibodies; pulmonary fibrosis.

Publication types

Letter
Comment

MeSH terms

Arthritis, Rheumatoid* / immunology
Autoantibodies
Humans
Lung Diseases, Interstitial* / immunology

Substances

Autoantibodies